Ligand Pharmaceuticals (LGND) Insider: Stock Move Analysis
A Ligand Pharmaceuticals insider recently sold 5,000 shares, triggering discussions about what insider moves signal f...
Deciding between broad market and sector funds depends on diversification needs and risk tolerance. This guide compares outcomes and helps you decide.
28,547 articlesA Ligand Pharmaceuticals insider recently sold 5,000 shares, triggering discussions about what insider moves signal f...
AI-driven signals suggest XRP could break out to $1.40-$1.55 in the next 15 days, depending on clearing a key resista...
Kraken rolls out a Solana token flow that enables 2,500+ on-chain tokens to trade inside the main app, but tokens rem...
Investors chasing steady monthly income via QYLD face a trade-off: the cost of covered-call income can outpace Nasdaq...
June brought a tighter landscape for mortgage credit as government-backed programs pulled back, pushing the MBA’s MCA...
Oil prices rose amid geopolitical tension and supply risks, signaling that prices could back toward the $5 gallon ran...
SOL broke past $93, turning a weeks-long distribution zone into a potential floor. Analysts warn a quick squeeze coul...
A surprise leadership change jolted Copart’s stock, sparking an intraday drop. This article breaks down the why, what...
Nebius is carving a niche in AI cloud services with data centers and ML software. This guide breaks down what buying ...
A noted economist who studied sports money foresees a record run for FIFA, with 2026 ticket receipts pushing revenue ...
As Absci releases its 2026 earnings outlook, investors gain a clearer view of runway, milestones, and collaboration p...
Plaid’s CFO highlights a surge in internal AI experiments as teams share weekend builds. The push comes as Plaid expa...